|
M.I. Kogan, Ig.V. Popov, Il. V. Popov, S.S. Todorov
Penile cavernous fibrosis: etiology, morphogenesis, erectile dysfunction
|
№4 / 2020
|
|
V.V. Borisov
Combination of α1-blockers and phosphodiesterase type 5 inhibitor in patients with benign prostatic hyperplasia and erectile dysfunction: results of observatory prospective multicenter study
|
№3 / 2020
|
|
N.D. Akhvlediani, A.S. Chernushenko, D.Yu. Pushkar, A.N. Bernikov, I.A. Reva
Surgical approaches for implanting of three-piece penile prosthetics
|
№6 / 2019
|
|
A.A. Kaputovskij
Tadalafil 5 mg once daily is a rationale option for simultaneous treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction
|
№6 / 2019
|
|
P.V. Glybochko, Z.K. Gadzhievа, Yu.G. Alyaev, M.A. Gazimiev
Multidisciplinary approach in urology. Clinical aspects
|
№4 (приложение) / 2019
|
|
A.A. Kaputovskij
The role of herbal therapy, vitamins and micronutrients formanagement of male sexual dysfunction and male infertility
|
№4 / 2019
|
|
A.A. Kamalov, A.N. Nizov
Efficiency of phosphodiesterase-5 inhibitors for treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia and concomitant erectile dysfunction
|
№4 / 2019
|
|
N.D. Akhvlediani, I.A. Reva, A.N. Bernikov, A.S. Chernushenko, D.Yu. Pushkar
Penile prosthesis implantation through subcoronal approach in patients with total cavernous fibrosis
|
№4 / 2019
|
|
S.I. Gamidov, V.M. Popkov, T.V. Shatylko, R.I. Ovchinnikov, A.Yu. Korolev, A.Yu. Popova, N.G. Gasanov
Erectile function after corporoplasty in patients with peyronie’s disease
|
№4 / 2019
|
|
N.D. Akhvlediani, D.Yu. Pushkar, A.N. Bernikov, A.S. Chernushenko, I.A. Reva
Penile prosthesis implantation through subcoronal approach with graft-free corporoplasty in patients with Peyronie disease with concomitant erectile dysfunction
|
№3 / 2019
|
|
A.A. Churakov, E.A. Bezrukov, A.B. Dolgov, D.V. Butnaru, G.A. Martirosyan, N.B. Zakharova, V.M. Popkov
Use of local baroimpulse therapy in the treatment of patients with chronic abacterial prostatitis / chronic pelvic pain syndrome and erectile dysfunction
|
№3 / 2019
|
|
I.L. Nikitina, G.G. Gaysina, Sh.N. Galimov, K.V. Bulygin, E.F. Galimova, V.N. Pavlov
Safety of tadalafil in patients with cardiovascular comorbidities
|
№1 / 2019
|
Русский
